Reg. 2 — Regulations, 2010
Reg. 2 · Regulations, 2010
Schedule XI to the principal regulations shall be Substitutes
Schedule XI to
substituted by the following
the principal
regulations.
* OJ L.39, 10-02-2009, p.34.
** OJ L.131, 16-05-2002, p.17.
"Schedule XI
Based on Annex I of Commission Decision 2009/108/EC of 3 February 2009 on
common technical specifications (CTS) for in vitro diagnostic medical devices
1. SCOPE
The common technical specifications set out in this Schedule shall apply
for the purposes of Schedule II, List A.
2. DEFINITIONS AND TERMS
(Diagnostic) sensitivity
The probability that the device gives a positive result in the presence of
the target marker.
True positive A specimen known to be positive for the target marker
and correctly classified by the device.
False negative A specimen known to be positive for the target marker
and misclassified by the device.
(Diagnostic) specificity The probability that the device gives a negative
result in the absence of the target marker.
False positive
A specimen known
to be negative for the target marker and
misclassified by the device.
True negative
A specimen known to be negative for the target marker and correctly
classified by the device.
Analytical sensitivity
Analytical sensitivity may be expressed as the limit of detection, i.e. the
smallest amount of the target marker that can be precisely detected.
Analytical specificity
Analytical specificity means the ability of the method to determine
solely the target marker.
Nucleic acid amplification techniques (NAT)
The term ‘NAT’ is used for tests for the detection and/or quantification
of nucleic acids by either amplification of a target sequence, by amplification
of a signal or by hybridisation.
Rapid test
‘Rapid test’ means qualitative or semi quantitative in vitro diagnostic
medical devices, used singly or in a small series, which involve non-
automated procedures and have been designed to give a fast result.
Robustness
The robustness of an analytical procedure means the capacity of an analytical
procedure to remain unaffected by small but deliberate variations in method
parameters and provides an indication of its reliability during normal usage.
Whole system failure rate
The whole system failure rate means the frequency of failures when the
entire process is performed as prescribed by the manufacturer.
Confirmation assay
Confirmation assay means an assay used for the confirmation of a reactive
result from a screening assay.
Virus typing assay
Virus typing assay means an assay used for typing with already known
positive samples, not used for primary diagnosis of infection or for screening.
Sero-conversion HIV samples
Sero-conversion HIV samples mean
-
p24 antigen and/or HIV RNA positive and;
-
recognised by all of the antibody screening tests and;
-
positive or indeterminate confirmatory assays.
Early sero-conversion HIV samples
Early sero-conversion HIV samples mean
-
p24 antigen and/or HIV RNA positive and;
-
not recognised by all of the antibody screening tests and;
-
indeterminate or negative confirmatory assays.